3,0
16. Okt. 2019
Ehemaliger Mitarbeiter, mehr als 1 Jahr
Richmond, VA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Being a CRO, the company is sheltered from FDA oversight in the commercial pharmaceutical industry. Several clients and independent research groups to gain exposure with
Kontras
Positions on 2nd shift languish from slow growth and poor communication